Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Buttyan

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Journal of Cellular Physiology|April 24, 2019
Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancerPeter A Raven, Summer Lysakowski, Zheng Tan, et al.
International Journal of Cancer|September 28, 2016
Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironmentAmy A Lubik, Mannan Nouri, Sarah Truong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2016
Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted TherapyTetsutaro Hayashi, Kilian M Gust, Alexander W Wyatt, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2011
Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ζ 2 renders tumor cells dependent on its paralogous gene COPZ1Michael Shtutman, Mirza Baig, Elina Levina, et al.
Oncotarget|June 4, 2015
Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cellsElina Levina, Hao Ji, Mengqiang Chen, et al.
Cancer Research|November 4, 2010
Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapyGuillaume Ploussard, Stéphane Terry, Pascale Maillé, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 2006
[Protocadherin-PC discovery and its implication in prostate cancer progression]Francis Vacherot, Stéphane Terry, Hugo Faucon, et al.
Scientific Reports|September 15, 2017
Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cellsKevin J Tam, Daniel H F Hui, Wilson W Lee, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 21, 2014
FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotypeDavid J DeGraff, Magdalena M Grabowska, Tom C Case, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate CancerMannan Nouri, Shabnam Massah, Josselin Caradec, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of Cellular Physiology|April 24, 2019
Inhibition of GLI2 with antisense-oligonucleotides: A potential therapy for the treatment of bladder cancerPeter A Raven, Summer Lysakowski, Zheng Tan, et al.
International Journal of Cancer|September 28, 2016
Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironmentAmy A Lubik, Mannan Nouri, Sarah Truong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2016
Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted TherapyTetsutaro Hayashi, Kilian M Gust, Alexander W Wyatt, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 13, 2011
Tumor-specific silencing of COPZ2 gene encoding coatomer protein complex subunit ζ 2 renders tumor cells dependent on its paralogous gene COPZ1Michael Shtutman, Mirza Baig, Elina Levina, et al.
Oncotarget|June 4, 2015
Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cellsElina Levina, Hao Ji, Mengqiang Chen, et al.
Cancer Research|November 4, 2010
Class III beta-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapyGuillaume Ploussard, Stéphane Terry, Pascale Maillé, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 2006
[Protocadherin-PC discovery and its implication in prostate cancer progression]Francis Vacherot, Stéphane Terry, Hugo Faucon, et al.
Scientific Reports|September 15, 2017
Semaphorin 3 C drives epithelial-to-mesenchymal transition, invasiveness, and stem-like characteristics in prostate cellsKevin J Tam, Daniel H F Hui, Wilson W Lee, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 21, 2014
FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotypeDavid J DeGraff, Magdalena M Grabowska, Tom C Case, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 11, 2020
Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate CancerMannan Nouri, Shabnam Massah, Josselin Caradec, et al.
Pageof 7